Trial Profile
A prospective, open-label study to evaluate the effect of an escalating dose regimen of trandolapril on blood pressure in treatment-naive and concurrently treated hypertensive patients (TRAIL)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Mar 2009
Price :
$35
*
At a glance
- Drugs Trandolapril (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms TRAIL
- 24 Mar 2009 Actual end date changed from Jun 2005 to Sep 2005 as reported by ClinicalTrials.gov.
- 21 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 05 Nov 2005 New trial record.